114 related articles for article (PubMed ID: 1332156)
1. Macrophage activation by OM-85 BV.
Mauël J
Respiration; 1992; 59 Suppl 3():14-8. PubMed ID: 1332156
[TBL] [Abstract][Full Text] [Related]
2. Stimulation by a bacterial extract (Broncho-Vaxom) of the metabolic and functional activities of murine macrophages.
Mauel J; Van Pham T; Kreis B; Bauer J
Int J Immunopharmacol; 1989; 11(6):637-45. PubMed ID: 2553625
[TBL] [Abstract][Full Text] [Related]
3. Metabolic and functional stimulation of lymphocytes and macrophages by an Escherichia coli extract (OM-89): in vitro studies.
Van Pham T; Kreis B; Corradin-Betz S; Bauer J; Mauël J
J Biol Response Mod; 1990 Apr; 9(2):231-40. PubMed ID: 2160522
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of assay procedures measuring macrophage stimulation by immunomodulators in vitro.
Mauël J; Pham TV; Kreis B; Corradin-Betz S; Bauer J
Dev Biol Stand; 1992; 77():71-7. PubMed ID: 1330790
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of immunoprotective mechanisms by OM-85 BV. A review of results from in vivo and in vitro studies.
Mauël J
Respiration; 1994; 61 Suppl 1():8-15. PubMed ID: 7800969
[TBL] [Abstract][Full Text] [Related]
6. Th1-orientated immunological properties of the bacterial extract OM-85-BV.
Huber M; Mossmann H; Bessler WG
Eur J Med Res; 2005 May; 10(5):209-17. PubMed ID: 15946922
[TBL] [Abstract][Full Text] [Related]
7. Human macrophage-activating factors for cytotoxicity. I. Establishment of a human T-cell hybridoma that produces macrophage-activating factors for cytotoxicity.
Higuchi M; Sugimoto M; Kobayashi Y; Osawa T
Microbiol Immunol; 1987; 31(5):469-79. PubMed ID: 3116371
[TBL] [Abstract][Full Text] [Related]
8. Lead inhibits intracellular killing of Leishmania parasites and extracellular cytolysis of target cells by macrophages exposed to macrophage activating factor.
Mauël J; Ransijn A; Buchmüller-Rouiller Y
J Leukoc Biol; 1989 May; 45(5):401-9. PubMed ID: 2496192
[TBL] [Abstract][Full Text] [Related]
9. The bacterial extract OM-85 BV protects mice against influenza and Salmonella infection.
Bessler WG; Vor dem Esche U; Masihi N
Int Immunopharmacol; 2010 Sep; 10(9):1086-90. PubMed ID: 20601184
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
Heidenreich S; Weyers M; Gong JH; Sprenger H; Nain M; Gemsa D
J Immunol; 1988 Mar; 140(5):1511-8. PubMed ID: 3126228
[TBL] [Abstract][Full Text] [Related]
11. Direct activation of murine peritoneal macrophages for nitric oxide production and tumor cell killing by interferon-gamma.
Dileepan KN; Page JC; Li Y; Stechschulte DJ
J Interferon Cytokine Res; 1995 May; 15(5):387-94. PubMed ID: 7648440
[TBL] [Abstract][Full Text] [Related]
12. gamma-Interferon enhances the secretion of arachidonic acid metabolites from murine peritoneal macrophages stimulated with phorbol diesters.
Hamilton TA; Rigsbee JE; Scott WA; Adams DO
J Immunol; 1985 Apr; 134(4):2631-6. PubMed ID: 3919102
[TBL] [Abstract][Full Text] [Related]
13. Lead inhibits oxidative metabolism of macrophages exposed to macrophage-activating factor.
Buchmüller-Rouiller Y; Ransijn A; Mauël J
Biochem J; 1989 Jun; 260(2):325-32. PubMed ID: 2669732
[TBL] [Abstract][Full Text] [Related]
14. In vivo study on the immunomodulating effects of OM-85 BV on survival, inflammatory cell recruitment and bacterial clearance in Klebsiella pneumonia.
Broug-Holub E; Kraal G
Int J Immunopharmacol; 1997; 19(9-10):559-64. PubMed ID: 9637354
[TBL] [Abstract][Full Text] [Related]
15. Bacterial extract OM-85 BV protects mice against experimental chronic rhinosinusitis.
Tao Y; Yuan T; Li X; Yang S; Zhang F; Shi L
Int J Clin Exp Pathol; 2015; 8(6):6800-6. PubMed ID: 26261565
[TBL] [Abstract][Full Text] [Related]
16. Selective augmentation by recombinant interferon-gamma of the intracellular content of S-adenosylmethionine in murine macrophages.
Bonvini E; Hoffman T; Herberman RB; Varesio L
J Immunol; 1986 Apr; 136(7):2596-604. PubMed ID: 3081646
[TBL] [Abstract][Full Text] [Related]
17. Induction of interleukin 6 and interleukin 8 expression by Broncho-Vaxom (OM-85 BV) via C-Fos/serum responsive element.
Keul R; Roth M; Papakonstantinou E; Nauck M; Perruchoud AP; Block LH
Thorax; 1996 Feb; 51(2):150-4. PubMed ID: 8711646
[TBL] [Abstract][Full Text] [Related]
18. OM-85 BV upregulates the expression of adhesion molecules on phagocytes through a CD 14-independent pathway.
Marchant A; Goldman M
Int J Immunopharmacol; 1996 Apr; 18(4):259-62. PubMed ID: 8894805
[TBL] [Abstract][Full Text] [Related]
19. Constitutive production of novel macrophage-activating factor(s) by human T cell hybridomas.
Taniyama T; Taki S; Akiyama Y; Yoshizawa K; Hamuro J; Arai K; Wong GG
Clin Invest Med; 1990 Dec; 13(6):305-12. PubMed ID: 2127737
[TBL] [Abstract][Full Text] [Related]
20. Chronic infection due to Mycobacterium intracellulare in mice: association with macrophage release of prostaglandin E2 and reversal by injection of indomethacin, muramyl dipeptide, or interferon-gamma.
Edwards CK; Hedegaard HB; Zlotnik A; Gangadharam PR; Johnston RB; Pabst MJ
J Immunol; 1986 Mar; 136(5):1820-7. PubMed ID: 3005400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
